Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extended Post-Operative Oral Tranexamic Acid Dosing After ACL Reconstruction: A Multicenter Randomized Controlled Trial

NCT07115056 is registered in ClinicalTrials.gov with Campbell Clinic as lead sponsor.

NCT NCT07115056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07115056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extended Post-Operative Oral Tranexamic Acid Dosing After ACL Reconstruction: A Multicenter Randomized Controlled Trial
Lead sponsor
Campbell Clinic
Phase
Phase 4
Overall status
Withdrawn
Start date
April 1, 2026
Completion date
December 31, 2029
Enrollment
0 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

acl injury, acl surgery, acl tears